Camber Launches Colchicine Capsules
Click to listen to this article.
Piscataway, NJ, July 29, 2025 – As a leader in generic drug approvals and launches, Camber Pharmaceuticals is excited to announce the addition of Colchicine Capsules [coll-chi-seen] to its current portfolio.
Colchicine Capsules are indicated for prophylaxis of gout flares in adults. Colchicine works by stopping the natural processes that cause swelling and other symptoms of gout.
Colchicine Capsules are available in 0.6 mg, 30 and 100 count bottles.
To learn more about Colchicine Capsules, please visit: www.camberpharma.com/colchicine
Recent articles
- Camber Specialty Marks First Day 1 Injectable Launch
- New to Camber’s Portfolio: Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets
- Camber Pharmaceuticals Honored as Second Merit Finalist at 2026 DIANA Awards
- Camber Launches Nitazoxanide Tablets
- Cisatracurium Besylate Injection, USP Added to Camber’s Portfolio
- Camber Welcomes Summer 2026 Intern Class






